John K. Lee is a physician-scientist and Associate Professor-in-Residence in the Division of Hematology/Oncology, Department of Medicine; Department of Molecular and Medical Pharmacology; and the Institute for Urologic Oncology, Department of Urology at the David Geffen School of Medicine at UCLA. He received an A.B. with highest honors in Biochemical Sciences at Harvard University and an M.D. at the Geisel School of Medicine at Dartmouth during which he participated in the HHMI-NIH Research Scholars Program. Dr. Lee completed his clinical training in internal medicine at Boston Medical Center and Specialty Training and Advanced Research (STAR) fellowship in medical oncology at UCLA where he obtained a Ph.D. from the Molecular Biology Institute under the mentorship of Dr. Owen Witte. He specializes in genitourinary oncology, specifically caring for patients with advanced prostate and bladder cancer. Dr. Lee also leads a federally funded basic and translational research laboratory within the UCLA Jonsson Comprehensive Cancer Center  and the Parker Institute for Cancer Immunotherapy at UCLA focused on untangling diverse genotype-phenotype relationships in cancer and developing new immune-based strategies to effectively treat prostate and bladder cancer. He is an elected member of the American Society for Clinical Investigation and is the recipient of an NIH Director’s New Innovator Award, Prostate Cancer Foundation Young Investigator and Challenge Awards, Society for Basic Urologic Research Young Investigator and Eula and Donald S. Coffey Innovative Research Awards, Bladder Cancer Advocacy Network Research Innovation Award, and multiple awards from the U.S. Department of Defense.